Sprachauswahl

Renate & Hans Schleussner Award

Applicants profile

Scientists or clinicians with innovative ideas relevant to the prevention or treatment of viral infections (e.g. HBV, CMV, VZV and Covid-19) with hyper-immunoglobulins are invited to submit their application. Projects can be in early stage or already progressed. Applications are encouraged from both individuals and teams conducting research at hospitals, universities or independent institutions. 

Applications are evaluated on the basis of four criteria by an independent jury. The project with the highest score is awarded.

Applicants must submit an original research contribution to basic or clinical research in the area of prevention or treatment viral infections with hyper-immunoglobulins. Projects should be related to pathology or management of the disease.

  • Applicants must present a research project with goals achieved within twenty four (24) months from the award assignment.
  • Applicants must be employed or supported by a hospital, university or independent research institution.

Participants must submit:

If the applicants PC is selected by the jury for the shortlist, the submission of a full project proposal is required including:

  • Study protocol
  • Project plan with time lines and cost estimations


By sending a Project Concept applicants agree to the further terms and conditions for applications, outlined below:

  • Applicants authorizes Biotest to retain and use their personal information filed for the entire application period.
  • Biotest warrants that all personal information and project proposals will be treated confidentially and will not be disclosed to third parties. For further details, please refer to​​​​​​​ Terms and Conditions.